Adrenergic drugs for urinary incontinence in adults

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 12, 2005, Pages

  Alhasso, Ammar ^a   Glazener, Cathryn MA ^b   Pickard, Robert ^c   N'Dow, James MO ^d  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; MIDODRINE; PHENYLPROPANOLAMINE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STRESS INCONTINENCE; URINE INCONTINENCE;

ADRENERGIC AGONISTS; ADULT; CLENBUTEROL; FEMALE; HUMANS; MIDODRINE; PHENYLPROPANOLAMINE; RANDOMIZED CONTROLLED TRIALS; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS;

EID: 32944481830     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001842.pub2     Document Type: Review

References (55)

1. Ahlstrom K, Sandahl B, Sjoberg B, Ulmsten U, Stormby N, Lindskog M. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence. Gynecologic & Obstetric Investigation 1990;30(1):37-43. [MEDLINE: 91033282]
2. Ani IF. The place of alpha-adrenergic agonist in the management of genuine stress incontinence of urine (Thesis). Master of Obstetrics and Gynaecology, University of Liverpool 1987.
3. Beisland HO, Fossberg E, Moer A, Sander S. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urologia Internationalis 1984;39(4):211-6. [MEDLINE: 85018049]
4. Collste L, Lindskog M. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients. Urology 1987;30(4):398-403. [MEDLINE: 88019058]
5. Ek A, Andersson KE, Gullerg B, Ulmsten U. The effect of long-term treatment with norepinephrine on stress incontinence and urethral closure pressure profile. Scandinavian Journal of Urology and Nephrology 1978;12(2):105-10.
6. Ek A, Andersson KE, Gullberg B, Ulmsten U. Effects of oestradiol and combined norephidrin and oestradiol treatment on female stress incontinence. Zentralblatt fur Gynakologie 1980;102(15):839-44.
7. Fossberg E, Beisland HO, Lundgren RA. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation. Urologia Internationalis 1983;38(5):293-9. [MEDLINE: 84046310]
8. Gibson JS, Dwyer P, Anderson RS, Pardey J. A multicentre controlled double dummy parallel group study of the effectiveness of mazindol vs eskornade vs placebo in stress incontinence. Proceedings of the International Continence Society (ICS), 19th Annual Meeting; 1989 Sept 7-9; Ljubljana, Slovenia. 1989:192-3.
9. Gnad H, Burmucic R, Petritsch P, Steindorfer P. Conservative therapy of female stress incontinence. Double-blind study with the alpha-sympathomimetic midodrin. [German]. Fortschritte der Medizin 1984;102(20):578-80. [MEDLINE: 84237884]
10. Gruneberger A. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. British Journal of Obstetrics and Gynaecology 1984;91(3):275-8.
11. Hilton P, Stanton SL. The use of phenylpropanolamine in genuine stress incontinence. Proceedings of the International Continence Society (ICS), 12th Annual Meeting; Leiden, Germany. 1982:23-4.
12. Hilton P, Tweddell AL, Mayne C. Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence. International Urogynaecology Journal 1990;1:80-6.
13. Ishiko O, Ushiroyama T, Saji F, Mitsuhashi Y, Tamura T, Yamamoto K, et al. Beta(2)-adrenergic agonists and pelvic floor exercises for female stress incontinence. International Journal of Gynaecology & Obstetrics 2000;71(1):39-44.
14. Kinn AC, Lindskog M. Estrogens and phenylpropanolamine as a combined treatment for stress incontinence in post menopausal women. Proceedings of the International Continence Society (ICS), 15th Annual Meeting; 1985 Sept 3-6; London, UK. 1985:401-2.
15. Kinn AC, Lindskog M. Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women. Urology 1988;32(3):273-80. [MEDLINE: 88322669]
16. Kromann B, Nielsen KK, Jakobsen H, Poulsen A, Nordling J, Ibsen T. Terbutaline (Bricanyl) in the treatment of frequency and urge incontinence, a placebo controlled study (Abstract). Proceedings of the International Continence Society (ICS), 21st Annual Meeting; 1991 Oct 10-12; Hannover, Federal Republic of Germany. 1991:172-3.
17. Lehtonen T, Rannikko S, Lindell O, Talja M, Wuokko E, Lindskog M. The effect of phenylpropanolamine on female stress urinary incontinence. Annales Chirurgiae et Gynaecologiae 1986;75(4):236-41. [MEDLINE: 87047356]
18. Lose G, Diernaes E, Rix P. Does Medical therapy Cure Female Stress incontinence?. Urology International 1989;44:25-7.
19. Lose G, Rix P, Diernaes E, Alexander N. Norfenefrine in the treatment of female stress incontinence. Urology International 1988;43(1):11-5.
20. Musselman DM, Ford APDW, Gennevois DJ, Harbison ML, Laurent AL, Stoltz RR. A randomised crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. BJU International 2004;93(1):78-83.
21. Walter S, Kjaergaard B, Lose G, Andersen JT, Heisterberg L, Jakobsen H, et al. Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha-adrenoceptor-stimulating agent (phenylpropanolamine): a randomised double-blind placebo-controlled study. International Urogynaecology Journal 1990;1:74-9.
22. Weil E, Dijkman G, Ralph G, Feyereisl J, Vierhout E, Eerdmans P. The effect of the alpha-1-adrenoceptor selective agonist midodrine on mild to moderate female stress-incontinence. Proceedings of the International Continence Society (ICS), 25th Annual Meeting; 1995 Oct 17-20, Sydney, Australia. 1995:50-1.
23. Weil E, Eerdmans P, van Waalwijk van Doorn E, Ralph G, Janknegt R. The effect of the alpha-1-adrenoceptor selective agonist midodrine on mild to moderate female stress-incontinence. Neurourology & Urodynamics 1994;13(4):446-7.
24. Weil EH, Eerdmans PH, Dijkman GA, Tamussino K, Feyereisl J, Vierhout, ME, et al. Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. International Urogynecology Journal & Pelvic Floor Dysfunction 1998;9(3):145-50. [MEDLINE: 98417055]
25. Wells TJ, Brink CA, Diokno AC, Wolfe R, Gillis GL. Pelvic muscle exercise for stress urinary incontinence in elderly women. Journal of the American Geriatrics Society 1991;39(8):785-91. [MEDLINE: 91302675]
26. Yasuda K, Kawabe K, Takimoto Y, Kondo A, Takaki R, Imabayashi K, et al. A double-blind clinical trial of a beta2-adrenergic agonist in stress incontinence. International Urogynecology Journal 1993;4:146-51.
27. Yasuda K, Kawabe K, Takimoto Y, Shimazaki J. Effects of clenbuterol on stress incontinence. Neurourology & Urodynamics 1990;9(4):341-2.
28. Amark P, Beck O. Effect of phenylpropanolamine on incontinence in children with neurogenic bladders. A double-blind crossover study. Acta Paediatrica 1992;81(4):345-50.
29. Farghaly S. Clinical trial of mazindol in the control of female stress urinary incontinence (Abstract). Proceedings of the American Urogynecology Society, 8th Annual Meeting; 1987 Sept 9-13; San Francisco, California. 1987.
30. Fossberg E, Beisland HO, Sander S. Sensory urgency in females: treatment with phenylpropanolamine. European Urology 1981;7(3):157-60. [MEDLINE: 81138293]
31. Jackobsen H, Steven K. Lack of effect of cholinergic blocking and alpha-adrenergic stimulation on noctural incontinence after ileocaecal bladder replacement. British Journal of Urology 1989;63:379-83.
32. Jorgensen L, Lose G, Alexander N. Acute effect of norfenefrine on the urethral pressure profile in females with genuine stress incontinence. Urologia Internationalis 1991;46(2):176-9.
33. Radley SC, Chapple CR, Bryan NP, Clarke DE, Craig DA. Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo-controlled, double-blind crossover study. Neurourology & Urodynamics 2001;20(1):43-52.
34. Radley SC, Chapple CR, Bryan NP, Craig D, Clarke DE. Effects of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo controlled, double blind crossover study. Proceedings of the 29th Annual Meeting of the International Continence Society (ICS); 1999 Aug 23-26; Denver, Colorado. 1999:383.
35. Woodhouse CR, Tiptaft RC. Mazindol in the control of micturition. British Journal of Urology 1983;55(6):636-8. [84081265]
36. Zinner N, Dmochowski R, Miklos J, Norton P, Yalcin I, Bump R. Duloxetine versus placebo in the treatment of stress urinary incontinence (SUI) (Abstract). Neurourology and Urodynamics 2002;21(4):383-4.
37. Black NA, Downs SH. The effectiveness of surgery for stress incontinence in women: a systematic review. British Journal of Urology 1996;78(4):497-510. [MEDLINE: 97099937]
38. Byland DB, Bond RA, Clarke DE, Eikenberg DC, Heible JP, Langer SZ, et al. The IUPHAR Receptor Code. The IUPHAR Compendium of Receptor Characterisation and Classification. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, 1998:59-74.
39. Clark JE, Simon WA. Cardiac arrhythmias after phenylpropanolamine ingestion. Drug Intelligene & Clinical Pharmacy 1983;17(10):737-8.
40. Deeks JJ, Higgins JPT, Altman DG, editors. Analysing and presenting results. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 8. Available from: www.cochrane.org.resources/handbook/hbook.htm (accessed 6th October 2006).
41. Emberton M, Neal DE, Black N, Fordham M, Harrison M, McBrien MP, et al. The effect of prostatectomy on symptom severity and quality of life. British Journal of Urology 1996;77:233-47.
42. Enhoring E. Simultaneous recording of intravesical and intraurethral pressure. Acta Chirurgica Scandinavica - Supplementum 1961;276:1-68.
43. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
44. Hunskaar S, Burgio KL, Diokno AC, Herzog AR, Hjalmas K, Lapitan MC. Epidemiology and natural history of urinary incontinence. Incontinence: 2nd International Consultation on Incontinence. Plymouth, UK: Health Publication Ltd, 2002:165-202.
45. Hunter KF, Glazener CMA, Moore KN. Conservative management for postprostatectomy urinary incontinence. Cochrane Database of Systematic Reviews 2007, Issue 2. [Art. No.: CD001843. DOI: 10.1002/14651858.CD001843.pub3]
46. Kava MS, Blue DR Jr, Vimont RL, Clarke DE, Ford AP. Alpha 1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. British Journal of Pharmacology 1998;123(7):1359-66. [MEDLINE: 98239334]
47. Lapitan MC, Cody DJ, Grant AM. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews 2005, Issue 3. [Art. No.: CD002912. DOI: 10.1002/14651858.CD002912.pub2]
48. Mariappan P, Ballantyne Z, N'Dow JMO, Alhasso AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews 2005, Issue 3. [Art. No.: CD004742. DOI: 10.1002/14651858.CD004742.pub2]
49. McGuire EJ. Diagnosis and treatment of intrinsic sphincter deficiency. International Journal of Urology 1995;2(Suppl 1):7-10, 16-8. [MEDLINE: 95339254]
50. Meyer S, De Grandi P, Schmidt N, Sanzeni W, Spinosa JP. Urodynamic parameters in patients with slight and severe genuine stress incontinence: is the stress profile useful?. Neurourology & Urodynamics 1994;13(1):21-8. [MEDLINE: 94207393]
51. Michel MC, Taguchi K, Schafers RS, Williams TJ, Clarke DE, Ford AP. Alpha 1-adrenoceptor subtypes in the human cardiovascular and urogenital systems. Advances in Pharmacology 1998;42:394-8. [MEDLINE: 97468858]
52. Morita T. [Experimental studies for urinary incontinence. Effect of beta 2- agonists on the vesicourethral function]. Nippon Hinyokika Gakkai Zasshi - Japanese Journal of Urology 1989;80(11):1597-604. [MEDLINE: 90080499]
53. Pickard R, Reaper J, Wyness L, Cody DJ, McClinton S, N'Dow J. Periurethral injection therapy for urinary incontinence in women. Cochrane Database of Systematic Reviews 2003, Issue 2. [Art. No.: CD003881. DOI: 10.1002/14651858.CD003881]
54. Swift SE, Ostergard DR. Evaluation of current urodynamic testing methods in the diagnosis of genuine stress incontinence. Obstetrics & Gynecology 1995;86(1):85-91. [MEDLINE: 95303440]
55. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. British Medical Journal 1980;281(6250):1243-5. [MEDLINE: 81041506]